Healthcare Sector Stocks
The Healthcare sector has a total of 1056 stocks, with a combined market cap of $8.73 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 43.77.
Market Cap
8.73T
Revenue
4.59T
Profits
199.4B
PE Ratio
43.77
Profit Margin
4.34%
Dividend Yield
0.41%
1057 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 999.19B | 0.29% | 1,268,301 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 590.06B | 1.71% | 4,345,505 | 96.36B |
| 3 | ABBV | AbbVie Inc. | 429.26B | 3.44% | 3,777,210 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 376.91B | 2.27% | 3,037,922 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 305.52B | 2.57% | 4,789,631 | 65.77B |
| 6 | AZN | AstraZeneca PLC | 288.22B | 1.11% | 956,537 | 60.44B |
| 7 | NVS | Novartis AG | 280.29B | 1.33% | 3,066,059 | 56.58B |
| 8 | NVO | Novo Nordisk A/S | 212.99B | 0.15% | 6,102,608 | 50.57B |
| 9 | AMGN | Amgen Inc. | 191.99B | 1.22% | 792,147 | 37.22B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 188.70B | 3.17% | 1,423,231 | 45.20B |
| 11 | ABT | Abbott Laboratories | 162.69B | 3.22% | 7,253,604 | 45.13B |
| 12 | GILD | Gilead Sciences, Inc. | 154.10B | -0.83% | 3,244,107 | 29.74B |
| 13 | ISRG | Intuitive Surgical, Inc. | 141.80B | -0.36% | 1,161,119 | 10.58B |
| 14 | DHR | Danaher Corporation | 137.57B | 2.91% | 3,391,586 | 24.78B |
| 15 | PFE | Pfizer Inc. | 136.07B | -0.69% | 27,460,436 | 63.32B |
| 16 | CVS | CVS Health Corporation | 132.75B | 2.14% | 4,138,752 | 405.62B |
| 17 | VRTX | Vertex Pharmaceuticals Incorporated | 122.63B | 1.68% | 657,324 | 12.22B |
| 18 | SYK | Stryker Corporation | 121.87B | 1.35% | 1,118,545 | 25.27B |
| 19 | BMY | Bristol-Myers Squibb Company | 113.95B | 1.45% | 4,472,653 | 48.48B |
| 20 | MDT | Medtronic plc | 104.00B | 1.40% | 3,342,838 | 36.36B |
| 21 | GSK | GSK plc | 102.31B | 1.70% | 1,756,081 | 43.29B |
| 22 | SNY | Sanofi | 100.27B | 1.19% | 3,322,935 | 54.60B |
| 23 | MCK | McKesson Corporation | 90.29B | 0.60% | 562,950 | 403.43B |
| 24 | HCA | HCA Healthcare, Inc. | 86.32B | 0.35% | 518,549 | 76.39B |
| 25 | ELV | Elevance Health, Inc. | 83.54B | 0.17% | 764,127 | 200.42B |
| 26 | CI | The Cigna Group | 74.78B | 1.15% | 396,817 | 277.89B |
| 27 | BSX | Boston Scientific Corporation | 65.83B | -0.38% | 9,261,499 | 20.61B |
| 28 | REGN | Regeneron Pharmaceuticals, Inc. | 63.80B | 0.59% | 304,746 | 14.92B |
| 29 | COR | Cencora, Inc. | 56.10B | 1.37% | 604,105 | 328.68B |
| 30 | CAH | Cardinal Health, Inc. | 54.63B | 0.10% | 649,856 | 250.74B |
| 31 | ARGX | argenx SE | 52.88B | 4.48% | 312,655 | 4.74B |
| 32 | EW | Edwards Lifesciences Corporation | 51.93B | 0.59% | 1,694,947 | 6.30B |
| 33 | TAK | Takeda Pharmaceutical Company Limited | 49.36B | -0.70% | 1,469,659 | 28.34B |
| 34 | MDLN | Medline Inc. | 48.87B | 3.19% | 3,699,853 | 29.14B |
| 35 | HUM | Humana Inc. | 45.02B | 3.68% | 481,085 | 137.20B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 43.83B | 1.19% | 316,266 | 4.45B |
| 37 | BDX | Becton, Dickinson and Company | 41.80B | 2.65% | 981,101 | 22.23B |
| 38 | HLN | Haleon plc | 40.39B | 0.33% | 4,680,819 | 14.85B |
| 39 | TEVA | Teva Pharmaceutical Industries Limited | 39.79B | -0.15% | 3,157,014 | 17.35B |
| 40 | ALNY | Alnylam Pharmaceuticals, Inc. | 38.92B | -0.86% | 582,520 | 4.29B |
| 41 | A | Agilent Technologies, Inc. | 38.76B | 4.26% | 922,804 | 7.23B |
| 42 | RVMD | Revolution Medicines, Inc. | 37.64B | 4.30% | 3,393,836 | - |
| 43 | NTRA | Natera, Inc. | 37.60B | 0.98% | 1,300,476 | 2.50B |
| 44 | WAT | Waters Corporation | 36.92B | 1.84% | 411,775 | 3.77B |
| 45 | ALC | Alcon Inc. | 33.59B | 0.69% | 617,987 | 10.63B |
| 46 | ZTS | Zoetis Inc. | 32.66B | -0.35% | 1,737,657 | 9.53B |
| 47 | CNC | Centene Corporation | 31.96B | 2.79% | 1,890,536 | 178.33B |
| 48 | RPRX | Royalty Pharma plc | 31.67B | 1.33% | 1,349,762 | 2.44B |
| 49 | IQV | IQVIA Holdings Inc. | 31.18B | 0.65% | 843,085 | 16.63B |
| 50 | ONC | BeOne Medicines AG | 30.86B | 0.17% | 124,693 | 5.70B |
| 51 | BIIB | Biogen Inc. | 30.12B | 2.20% | 380,676 | 9.94B |
| 52 | GEHC | GE HealthCare Technologies Inc. | 29.58B | 0.22% | 2,303,835 | 20.98B |
| 53 | RMD | ResMed Inc. | 28.89B | 1.80% | 674,171 | 5.54B |
| 54 | ILMN | Illumina, Inc. | 27.46B | 3.66% | 1,310,692 | 4.39B |
| 55 | DXCM | DexCom, Inc. | 26.59B | -1.19% | 2,031,840 | 4.82B |
| 56 | VEEV | Veeva Systems Inc. | 25.88B | -1.25% | 633,677 | 3.32B |
| 57 | PHG | Koninklijke Philips N.V. | 25.56B | 1.91% | 480,599 | 20.34B |
| 58 | MTD | Mettler-Toledo International Inc. | 25.32B | 4.16% | 182,760 | 4.09B |
| 59 | WST | West Pharmaceutical Services, Inc. | 24.76B | 2.96% | 506,997 | 3.22B |
| 60 | ROIV | Roivant Sciences Ltd. | 24.46B | -0.03% | 4,528,353 | 8.26M |
| 61 | MRNA | Moderna, Inc. | 23.47B | -2.12% | 3,215,607 | 2.23B |
| 62 | UTHR | United Therapeutics Corporation | 23.38B | 0.15% | 111,101 | 3.17B |
| 63 | BNTX | BioNTech SE | 22.73B | -0.38% | 357,467 | 3.23B |
| 64 | DGX | Quest Diagnostics Incorporated | 22.71B | 1.02% | 283,014 | 11.28B |
| 65 | INSM | Insmed Incorporated | 22.65B | 0.99% | 1,973,671 | 819.56M |
| 66 | LH | Labcorp Holdings Inc. | 21.91B | 0.75% | 200,348 | 14.14B |
| 67 | INCY | Incyte Corporation | 21.44B | -1.06% | 791,790 | 5.36B |
| 68 | STE | STERIS plc | 20.63B | 2.20% | 337,807 | 5.94B |
| 69 | GH | Guardant Health, Inc. | 18.93B | 4.23% | 1,490,451 | 1.08B |
| 70 | VTRS | Viatris Inc. | 18.66B | 0.56% | 3,823,102 | 14.56B |
| 71 | ZBH | Zimmer Biomet Holdings, Inc. | 17.64B | 0.71% | 537,546 | 8.41B |
| 72 | NBIX | Neurocrine Biosciences, Inc. | 16.48B | -1.30% | 354,148 | 3.10B |
| 73 | GMAB | Genmab A/S | 16.10B | 0.91% | 788,179 | 3.90B |
| 74 | ASND | Ascendis Pharma A/S | 15.93B | 7.74% | 1,632,786 | 998.25M |
| 75 | THC | Tenet Healthcare Corporation | 15.89B | 0.83% | 197,930 | 21.46B |
| 76 | MEDP | Medpace Holdings, Inc. | 14.94B | 1.98% | 184,816 | 2.68B |
| 77 | BTSG | BrightSpring Health Services, Inc. | 14.39B | 2.17% | 1,420,610 | 13.65B |
| 78 | JAZZ | Jazz Pharmaceuticals plc | 14.27B | -1.03% | 257,624 | 4.44B |
| 79 | DVA | DaVita Inc. | 13.74B | 0.49% | 340,310 | 13.84B |
| 80 | COO | The Cooper Companies, Inc. | 13.66B | 1.76% | 1,240,260 | 4.23B |
| 81 | BBIO | BridgeBio Pharma, Inc. | 13.61B | 0.20% | 1,357,724 | 579.96M |
| 82 | SOLV | Solventum Corporation | 13.43B | 2.58% | 325,612 | 8.26B |
| 83 | EXEL | Exelixis, Inc. | 13.37B | 0.59% | 1,078,800 | 2.38B |
| 84 | IONS | Ionis Pharmaceuticals, Inc. | 13.02B | 2.98% | 1,311,101 | 1.06B |
| 85 | SNN | Smith & Nephew plc | 12.87B | 0.07% | 930,205 | 6.16B |
| 86 | FMS | Fresenius Medical Care AG | 12.86B | -2.79% | 523,489 | 22.32B |
| 87 | RVTY | Revvity, Inc. | 12.66B | 7.46% | 1,388,109 | 2.90B |
| 88 | ALGN | Align Technology, Inc. | 12.58B | 2.76% | 299,363 | 4.10B |
| 89 | ICLR | ICON Public Limited Company | 12.56B | 3.67% | 1,154,049 | 8.27B |
| 90 | PEN | Penumbra, Inc. | 12.48B | 0.33% | 200,121 | 1.45B |
| 91 | AXSM | Axsome Therapeutics, Inc. | 12.36B | 0.97% | 510,957 | 708.24M |
| 92 | ELAN | Elanco Animal Health Incorporated | 12.03B | 0.54% | 1,357,915 | 4.89B |
| 93 | RDY | Dr. Reddy's Laboratories Limited | 11.93B | 3.10% | 2,433,037 | 3.58B |
| 94 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.75B | - | 213,580 | 1.13B |
| 95 | GMED | Globus Medical, Inc. | 11.44B | 2.59% | 1,037,070 | 3.10B |
| 96 | MOH | Molina Healthcare, Inc. | 11.12B | 6.01% | 779,670 | 43.10B |
| 97 | ARWR | Arrowhead Pharmaceuticals, Inc. | 11.12B | -1.09% | 1,048,422 | 622.01M |
| 98 | BAX | Baxter International Inc. | 11.10B | 2.19% | 3,375,070 | 11.32B |
| 99 | BMRN | BioMarin Pharmaceutical Inc. | 11.05B | -0.24% | 630,166 | 3.24B |
| 100 | TECH | Bio-Techne Corporation | 11.04B | 19.76% | 41,172,513 | 1.21B |
| 101 | CYTK | Cytokinetics, Incorporated | 10.98B | -0.37% | 955,247 | 105.82M |
| 102 | SMMT | Summit Therapeutics Inc. | 10.95B | -0.98% | 2,163,708 | - |
| 103 | KRYS | Krystal Biotech, Inc. | 10.46B | 2.03% | 175,691 | 417.30M |
| 104 | PODD | Insulet Corporation | 10.44B | 1.28% | 498,686 | 2.90B |
| 105 | EHC | Encompass Health Corporation | 10.06B | -0.79% | 463,255 | 6.07B |
| 106 | CRL | Charles River Laboratories International, Inc. | 10.03B | 3.05% | 605,113 | 4.03B |
| 107 | APGE | Apogee Therapeutics, Inc. | 9.94B | -0.02% | 3,374,735 | - |
| 108 | NUVL | Nuvalent, Inc. | 9.76B | - | 681,735 | - |
| 109 | ENSG | The Ensign Group, Inc. | 9.68B | 1.76% | 391,047 | 5.27B |
| 110 | KYMR | Kymera Therapeutics, Inc. | 9.60B | 16.89% | 2,775,698 | 51.48M |
| 111 | TEM | Tempus AI, Inc. | 9.56B | 2.54% | 6,093,511 | 1.36B |
| 112 | HSIC | Henry Schein, Inc. | 9.53B | 1.06% | 294,499 | 13.38B |
| 113 | CORT | Corcept Therapeutics Incorporated | 9.26B | 5.75% | 481,198 | 769.10M |
| 114 | BRKR | Bruker Corporation | 9.17B | 3.05% | 1,556,627 | 3.46B |
| 115 | PRAX | Praxis Precision Medicines, Inc. | 8.88B | 3.15% | 433,243 | 7.46M |
| 116 | UHS | Universal Health Services, Inc. | 8.85B | 0.58% | 275,431 | 17.76B |
| 117 | ALKS | Alkermes plc | 8.62B | 2.46% | 1,618,012 | 1.56B |
| 118 | OSCR | Oscar Health, Inc. | 8.58B | -2.26% | 3,114,884 | 13.30B |
| 119 | HALO | Halozyme Therapeutics, Inc. | 8.57B | 1.52% | 685,540 | 1.51B |
| 120 | GKOS | Glaukos Corporation | 8.35B | 3.19% | 400,555 | 551.35M |
| 121 | RGEN | Repligen Corporation | 8.24B | 5.54% | 994,299 | 763.34M |
| 122 | QGEN | Qiagen N.V. | 8.08B | 0.85% | 2,052,248 | 2.10B |
| 123 | ATR | AptarGroup, Inc. | 8.03B | 1.19% | 87,013 | 3.87B |
| 124 | BIO | Bio-Rad Laboratories, Inc. | 8.02B | 7.06% | 398,903 | 2.59B |
| 125 | IBRX | ImmunityBio, Inc. | 7.98B | -2.31% | 5,780,790 | 140.98M |
| 126 | PTGX | Protagonist Therapeutics, Inc. | 7.94B | 1.06% | 453,200 | 74.06M |
| 127 | PCVX | Vaxcyte, Inc. | 7.82B | 0.54% | 567,574 | - |
| 128 | IMVT | Immunovant, Inc. | 7.81B | -0.52% | 676,290 | - |
| 129 | SYRE | Spyre Therapeutics, Inc. | 7.60B | 1.53% | 1,008,198 | - |
| 130 | TGTX | TG Therapeutics, Inc. | 7.60B | 0.07% | 806,103 | 700.35M |
| 131 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.33B | -0.49% | 314,595 | 217.17M |
| 132 | ABVX | ABIVAX Société Anonyme | 7.31B | -2.40% | 1,220,168 | 5.67M |
| 133 | MIRM | Mirum Pharmaceuticals, Inc. | 7.11B | 1.42% | 548,735 | 569.61M |
| 134 | HIMS | Hims & Hers Health, Inc. | 7.08B | -6.48% | 9,025,980 | 2.37B |
| 135 | PTCT | PTC Therapeutics, Inc. | 7.01B | 0.13% | 1,366,710 | 827.11M |
| 136 | LNTH | Lantheus Holdings, Inc. | 6.99B | 2.37% | 335,223 | 1.55B |
| 137 | HQY | HealthEquity, Inc. | 6.98B | -1.81% | 309,850 | 1.34B |
| 138 | AVTR | Avantor, Inc. | 6.87B | 3.77% | 4,342,745 | 6.55B |
| 139 | LQDA | Liquidia Corporation | 6.79B | 1.07% | 812,614 | 288.07M |
| 140 | COGT | Cogent Biosciences, Inc. | 6.50B | 1.35% | 1,827,735 | - |
| 141 | PACS | PACS Group, Inc. | 6.35B | 3.32% | 503,853 | 5.43B |
| 142 | SRRK | Scholar Rock Holding Corporation | 6.30B | 0.50% | 755,382 | - |
| 143 | GRFS | Grifols, S.A. | 6.27B | 1.73% | 326,796 | 8.58B |
| 144 | CGON | CG Oncology, Inc. | 6.19B | 2.11% | 618,546 | 5.07M |
| 145 | TWST | Twist Bioscience Corporation | 6.03B | 6.08% | 1,304,461 | 409.48M |
| 146 | CHE | Chemed Corporation | 5.99B | 1.24% | 87,044 | 2.54B |
| 147 | LGND | Ligand Pharmaceuticals Incorporated | 5.90B | 3.36% | 462,224 | 274.48M |
| 148 | BLTE | Belite Bio, Inc | 5.90B | -0.58% | 174,320 | - |
| 149 | TFX | Teleflex Incorporated | 5.68B | 1.47% | 122,398 | 2.13B |
| 150 | HNGE | Hinge Health, Inc. | 5.67B | 3.77% | 1,582,082 | 646.34M |
| 151 | BLCO | Bausch + Lomb Corporation | 5.65B | 2.19% | 161,630 | 5.21B |
| 152 | AMRX | Amneal Pharmaceuticals, Inc. | 5.60B | 1.68% | 906,569 | 3.05B |
| 153 | XENE | Xenon Pharmaceuticals Inc. | 5.49B | 2.13% | 591,256 | 7.50M |
| 154 | TVTX | Travere Therapeutics, Inc. | 5.42B | 1.12% | 1,990,150 | 536.20M |
| 155 | LEGN | Legend Biotech Corporation | 5.35B | -2.04% | 867,601 | 1.14B |
| 156 | CAI | Caris Life Sciences, Inc. | 5.34B | 4.13% | 2,148,687 | 907.29M |
| 157 | CRSP | CRISPR Therapeutics AG | 5.28B | 2.26% | 1,363,667 | 4.10M |
| 158 | BLLN | BillionToOne, Inc. | 5.19B | 4.76% | 572,111 | 354.54M |
| 159 | ORKA | Oruka Therapeutics, Inc. | 5.10B | 2.91% | 922,081 | - |
| 160 | DFTX | Definium Therapeutics, Inc. | 4.95B | 7.67% | 5,015,485 | - |
| 161 | MANE | Veradermics, Incorporated | 4.94B | 0.84% | 461,256 | - |
| 162 | DNTH | Dianthus Therapeutics, Inc. | 4.93B | -0.67% | 706,739 | 1.34M |
| 163 | INDV | Indivior Pharmaceuticals, Inc. | 4.91B | -2.82% | 906,448 | 1.29B |
| 164 | SHC | Sotera Health Company | 4.90B | 3.00% | 970,701 | 1.19B |
| 165 | STVN | Stevanato Group S.p.A. | 4.88B | 3.60% | 107,403 | 1.39B |
| 166 | CELC | Celcuity Inc. | 4.77B | 1.56% | 756,688 | - |
| 167 | VCYT | Veracyte, Inc. | 4.68B | 3.35% | 601,569 | 541.74M |
| 168 | ALHC | Alignment Healthcare, Inc. | 4.67B | 4.22% | 1,448,840 | 4.26B |
| 169 | RDNT | RadNet, Inc. | 4.64B | 1.48% | 435,325 | 2.14B |
| 170 | ERAS | Erasca, Inc. | 4.52B | -3.39% | 3,391,893 | - |
| 171 | EWTX | Edgewise Therapeutics, Inc. | 4.50B | -1.16% | 420,808 | - |
| 172 | LIVN | LivaNova PLC | 4.47B | 1.69% | 263,399 | 1.43B |
| 173 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.46B | -1.96% | 317,001 | 754.05M |
| 174 | TXG | 10x Genomics, Inc. | 4.44B | 1.07% | 1,350,273 | 638.78M |
| 175 | VKTX | Viking Therapeutics, Inc. | 4.44B | 0.92% | 2,786,730 | - |
| 176 | NVST | Envista Holdings Corporation | 4.33B | 2.17% | 740,255 | 2.81B |
| 177 | TNGX | Tango Therapeutics, Inc. | 4.24B | 0.62% | 2,445,535 | 56.99M |
| 178 | MMSI | Merit Medical Systems, Inc. | 4.21B | 1.88% | 242,182 | 1.54B |
| 179 | ACAD | ACADIA Pharmaceuticals Inc. | 4.01B | 0.36% | 757,007 | 1.10B |
| 180 | DNLI | Denali Therapeutics Inc. | 3.97B | 0.68% | 567,636 | - |
| 181 | MMED | MiniMed Group, Inc. | 3.96B | -0.21% | 237,029 | 3.10B |
| 182 | RLAY | Relay Therapeutics, Inc. | 3.89B | -0.89% | 1,779,460 | 10.68M |
| 183 | LFST | LifeStance Health Group, Inc. | 3.86B | 3.06% | 1,563,569 | 1.49B |
| 184 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.85B | 0.02% | 567,841 | 596.96M |
| 185 | RCUS | Arcus Biosciences, Inc. | 3.79B | 4.76% | 1,616,890 | 236.00M |
| 186 | NAMS | NewAmsterdam Pharma Company N.V. | 3.78B | -0.98% | 868,872 | 22.57M |
| 187 | IRTC | iRhythm Holdings, Inc. | 3.77B | 2.07% | 252,539 | 787.85M |
| 188 | CON | Concentra Group Holdings Parent, Inc. | 3.77B | 1.10% | 437,515 | 2.23B |
| 189 | RGC | Regencell Bioscience Holdings Limited | 3.72B | -12.21% | 310,231 | - |
| 190 | ICUI | ICU Medical, Inc. | 3.71B | 3.77% | 183,555 | 2.16B |
| 191 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.69B | -3.23% | 777,591 | 18.07M |
| 192 | TLX | Telix Pharmaceuticals Limited | 3.68B | -0.46% | 56,631 | 803.79M |
| 193 | DOCS | Doximity, Inc. | 3.63B | -4.58% | 1,300,254 | 644.86M |
| 194 | WAY | Waystar Holding Corp. | 3.63B | -0.42% | 689,455 | 1.16B |
| 195 | BKD | Brookdale Senior Living Inc. | 3.58B | 2.18% | 2,608,868 | 3.00B |
| 196 | OGN | Organon & Co. | 3.54B | -0.05% | 702,561 | 6.16B |
| 197 | GPCR | Structure Therapeutics Inc. | 3.49B | 2.08% | 347,367 | - |
| 198 | BEAM | Beam Therapeutics Inc. | 3.47B | 2.88% | 1,086,251 | 164.01M |
| 199 | HAE | Haemonetics Corporation | 3.43B | 3.65% | 239,820 | 1.33B |
| 200 | OPCH | Option Care Health, Inc. | 3.42B | -0.91% | 670,425 | 5.67B |
| 201 | ARQT | Arcutis Biotherapeutics, Inc. | 3.42B | -0.22% | 952,035 | 415.62M |
| 202 | DYN | Dyne Therapeutics, Inc. | 3.41B | 1.52% | 892,757 | - |
| 203 | WRBY | Warby Parker Inc. | 3.41B | 3.39% | 1,474,100 | 890.57M |
| 204 | PBLS | Parabilis Medicines, Inc. | 3.29B | -5.34% | 575,923 | - |
| 205 | ADPT | Adaptive Biotechnologies Corporation | 3.24B | 4.65% | 2,603,396 | 295.41M |
| 206 | IDYA | IDEAYA Biosciences, Inc. | 3.23B | 1.43% | 634,558 | 225.27M |
| 207 | ITGR | Integer Holdings Corporation | 3.16B | 1.94% | 90,233 | 1.86B |
| 208 | ALMS | Alumis Inc. | 3.16B | -0.20% | 541,111 | 8.40M |
| 209 | NHC | National HealthCare Corporation | 3.14B | -0.84% | 72,174 | 1.53B |
| 210 | QURE | uniQure N.V. | 3.12B | 1.43% | 1,534,922 | 18.09M |
| 211 | PRVA | Privia Health Group, Inc. | 3.10B | 0.41% | 308,009 | 2.25B |
| 212 | HTFL | HeartFlow, Inc. | 3.01B | 0.03% | 409,359 | 191.42M |
| 213 | ELVN | Enliven Therapeutics, Inc. | 3.00B | 3.06% | 962,542 | - |
| 214 | VERA | Vera Therapeutics, Inc. | 2.94B | 3.59% | 1,826,822 | - |
| 215 | GRAL | GRAIL, Inc. | 2.87B | 3.53% | 384,302 | 156.12M |
| 216 | RARE | Ultragenyx Pharmaceutical Inc. | 2.86B | 0.17% | 1,039,890 | 670.00M |
| 217 | TARS | Tarsus Pharmaceuticals, Inc. | 2.82B | -2.24% | 274,927 | 535.08M |
| 218 | CLOV | Clover Health Investments, Corp. | 2.72B | -0.77% | 3,092,526 | 2.21B |
| 219 | CLDX | Celldex Therapeutics, Inc. | 2.72B | 2.49% | 641,727 | 865.00K |
| 220 | KLRA | Kailera Therapeutics, Inc. | 2.68B | -3.28% | 138,429 | - |
| 221 | TMDX | TransMedics Group, Inc. | 2.67B | -0.56% | 509,223 | 635.89M |
| 222 | IRON | Disc Medicine, Inc. | 2.66B | -1.15% | 333,515 | - |
| 223 | ESTA | Establishment Labs Holdings Inc. | 2.62B | 1.93% | 242,241 | 229.58M |
| 224 | SUPN | Supernus Pharmaceuticals, Inc. | 2.61B | -0.38% | 278,569 | 776.83M |
| 225 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.48B | -2.30% | 14,706,759 | 885.72M |
| 226 | TRVI | Trevi Therapeutics, Inc. | 2.48B | -0.43% | 916,771 | - |
| 227 | GRDN | Guardian Pharmacy Services, Inc. | 2.44B | 0.37% | 214,519 | 1.46B |
| 228 | ACHC | Acadia Healthcare Company, Inc. | 2.40B | 4.65% | 1,664,013 | 3.37B |
| 229 | MBX | MBX Biosciences, Inc. | 2.38B | 3.10% | 760,094 | - |
| 230 | PHVS | Pharvaris N.V. | 2.37B | 1.96% | 287,127 | - |
| 231 | NRIX | Nurix Therapeutics, Inc. | 2.37B | 18.55% | 3,431,870 | 71.78M |
| 232 | BHVN | Biohaven Ltd. | 2.31B | 2.54% | 2,457,048 | - |
| 233 | AXGN | Axogen, Inc. | 2.30B | 1.79% | 584,568 | 238.11M |
| 234 | AUPH | Aurinia Pharmaceuticals Inc. | 2.30B | -4.03% | 1,184,106 | 298.30M |
| 235 | IMNM | Immunome, Inc. | 2.23B | -0.10% | 1,691,980 | 4.02M |
| 236 | PBH | Prestige Consumer Healthcare Inc. | 2.23B | -0.34% | 164,548 | 1.09B |
| 237 | NTLA | Intellia Therapeutics, Inc. | 2.21B | 2.06% | 1,877,860 | 66.09M |
| 238 | VCEL | Vericel Corporation | 2.17B | 2.15% | 289,454 | 292.09M |
| 239 | XRAY | DENTSPLY SIRONA Inc. | 2.16B | 2.66% | 1,883,071 | 3.68B |
| 240 | OCUL | Ocular Therapeutix, Inc. | 2.15B | -0.15% | 1,397,302 | 52.04M |
| 241 | LMAT | LeMaitre Vascular, Inc. | 2.15B | 2.07% | 165,187 | 256.28M |
| 242 | AGIO | Agios Pharmaceuticals, Inc. | 2.15B | -0.41% | 348,072 | 66.05M |
| 243 | MLYS | Mineralys Therapeutics, Inc. | 2.15B | 0.91% | 434,724 | - |
| 244 | GENB | Generate Biomedicines, Inc. | 2.14B | 2.96% | 415,107 | 30.30M |
| 245 | KOD | Kodiak Sciences Inc. | 2.14B | -4.72% | 525,579 | - |
| 246 | ASTH | Astrana Health, Inc. | 2.12B | 1.32% | 226,255 | 3.53B |
| 247 | PGNY | Progyny, Inc. | 2.11B | 0.41% | 345,860 | 1.29B |
| 248 | NKTR | Nektar Therapeutics | 2.11B | -3.78% | 364,207 | 55.63M |
| 249 | ZLAB | Zai Lab Limited | 2.09B | 1.06% | 306,807 | 453.28M |
| 250 | BFLY | Butterfly Network, Inc. | 2.07B | 2.06% | 4,122,131 | 102.92M |
| 251 | NEOG | Neogen Corporation | 2.07B | 3.38% | 656,062 | 870.56M |
| 252 | SEM | Select Medical Holdings Corporation | 2.05B | -0.18% | 6,321,721 | 5.52B |
| 253 | NUVB | Nuvation Bio Inc. | 2.05B | -8.82% | 11,214,843 | 143.05M |
| 254 | ABCL | AbCellera Biologics Inc. | 2.04B | 10.86% | 8,949,070 | 79.21M |
| 255 | ADMA | ADMA Biologics, Inc. | 2.03B | 0.57% | 1,343,742 | 509.86M |
| 256 | SLS | SELLAS Life Sciences Group, Inc. | 2.00B | 17.01% | 10,198,593 | - |
| 257 | AMLX | Amylyx Pharmaceuticals, Inc. | 2.00B | 5.59% | 1,692,752 | -665.00K |
| 258 | BHC | Bausch Health Companies Inc. | 1.99B | 7.01% | 2,075,424 | 10.53B |
| 259 | SGRY | Surgery Partners, Inc. | 1.99B | 0.79% | 471,500 | 3.34B |
| 260 | HRMY | Harmony Biosciences Holdings, Inc. | 1.97B | -1.19% | 162,938 | 899.11M |
| 261 | WGS | GeneDx Holdings Corp. | 1.96B | 3.87% | 457,933 | 442.68M |
| 262 | PGEN | Precigen, Inc. | 1.96B | 1.57% | 2,798,730 | 31.60M |
| 263 | UFPT | UFP Technologies, Inc. | 1.95B | 3.96% | 128,427 | 608.85M |
| 264 | KARD | Kardigan, Inc. | 1.94B | -1.27% | 118,458 | - |
| 265 | VRDN | Viridian Therapeutics, Inc. | 1.93B | 1.10% | 704,840 | 70.92M |
| 266 | SION | Sionna Therapeutics, Inc. | 1.93B | 3.89% | 267,475 | - |
| 267 | MD | Pediatrix Medical Group, Inc. | 1.93B | -0.87% | 339,318 | 1.93B |
| 268 | PVLA | Palvella Therapeutics, Inc. | 1.92B | 3.11% | 118,729 | - |
| 269 | STOK | Stoke Therapeutics, Inc. | 1.92B | 1.38% | 459,905 | 32.08M |
| 270 | RAPP | Rapport Therapeutics, Inc. | 1.90B | -0.59% | 233,760 | 20.00M |
| 271 | LKFT | Lakefront Biotherapeutics NV | 1.90B | -0.71% | 73,685 | 1.20B |
| 272 | IOVA | Iovance Biotherapeutics, Inc. | 1.87B | -1.65% | 5,633,460 | 285.61M |
| 273 | AVAH | Aveanna Healthcare Holdings Inc. | 1.86B | 1.00% | 1,073,841 | 2.52B |
| 274 | MESO | Mesoblast Limited | 1.86B | -6.53% | 279,039 | 65.38M |
| 275 | TYRA | Tyra Biosciences, Inc. | 1.85B | 2.34% | 267,710 | - |
| 276 | GLUE | Monte Rosa Therapeutics, Inc. | 1.84B | 4.65% | 842,970 | 42.95M |
| 277 | SNDA | Sonida Senior Living, Inc. | 1.82B | 1.21% | 480,867 | 367.34M |
| 278 | CMPS | COMPASS Pathways plc | 1.82B | 6.92% | 2,177,077 | - |
| 279 | HCM | HUTCHMED (China) Limited | 1.81B | 1.07% | 17,102 | 548.51M |
| 280 | PLSE | Pulse Biosciences, Inc. | 1.80B | 1.70% | 84,758 | 751.00K |
| 281 | TSHA | Taysha Gene Therapies, Inc. | 1.79B | -10.01% | 8,223,413 | 7.47M |
| 282 | OMCL | Omnicell, Inc. | 1.79B | -0.28% | 448,692 | 1.23B |
| 283 | NEO | NeoGenomics, Inc. | 1.79B | 6.59% | 2,028,748 | 745.97M |
| 284 | ADUS | Addus HomeCare Corporation | 1.78B | -0.06% | 65,217 | 1.45B |
| 285 | SNDX | Syndax Pharmaceuticals, Inc. | 1.78B | 0.30% | 623,063 | 217.17M |
| 286 | RXRX | Recursion Pharmaceuticals, Inc. | 1.78B | 3.56% | 10,858,599 | 66.41M |
| 287 | ALMR | Alamar Biosciences, Inc. | 1.77B | 7.30% | 307,625 | 87.16M |
| 288 | ANIP | ANI Pharmaceuticals, Inc. | 1.76B | 0.21% | 108,546 | 923.71M |
| 289 | BCAX | Bicara Therapeutics Inc. | 1.75B | 4.13% | 719,964 | - |
| 290 | ZYME | Zymeworks Inc. | 1.75B | -1.36% | 220,309 | 81.26M |
| 291 | AGL | agilon health, inc. | 1.75B | -2.14% | 216,614 | 5.82B |
| 292 | CAPR | Capricor Therapeutics, Inc. | 1.74B | 2.07% | 559,694 | 11.13M |
| 293 | ANAB | AnaptysBio, Inc. | 1.74B | 2.45% | 150,710 | 232.39M |
| 294 | AKTS | Aktis Oncology, Inc. | 1.74B | 9.65% | 474,282 | 8.28M |
| 295 | NBTX | Nanobiotix S.A. | 1.74B | 0.06% | 41,246 | 38.27M |
| 296 | GHRS | GH Research PLC | 1.73B | 2.26% | 99,719 | - |
| 297 | ATAI | AtaiBeckley Inc. | 1.72B | 12.23% | 7,884,023 | 3.49M |
| 298 | INVA | Innoviva, Inc. | 1.72B | -1.40% | 243,665 | 420.69M |
| 299 | NVCR | NovoCure Limited | 1.72B | 0.82% | 558,346 | 674.41M |
| 300 | SRPT | Sarepta Therapeutics, Inc. | 1.71B | -3.02% | 1,344,062 | 2.18B |
| 301 | URGN | UroGen Pharma Ltd. | 1.69B | -2.03% | 198,724 | 140.49M |
| 302 | VIR | Vir Biotechnology, Inc. | 1.69B | 0.70% | 697,710 | 65.50M |
| 303 | FTRE | Fortrea Holdings Inc. | 1.68B | 4.11% | 781,788 | 2.71B |
| 304 | HCSG | Healthcare Services Group, Inc. | 1.63B | 0.47% | 145,231 | 1.85B |
| 305 | TRLV | Trulieve Cannabis Corp. | 1.61B | -1.76% | 1,320,247 | 1.17B |
| 306 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.56B | 5.03% | 3,042,832 | 204.73M |
| 307 | SEPN | Septerna, Inc. | 1.56B | -3.94% | 140,923 | 72.26M |
| 308 | HROW | Harrow, Inc. | 1.55B | -2.28% | 374,640 | 268.68M |
| 309 | IMCR | Immunocore Holdings plc | 1.55B | 1.70% | 577,657 | 412.81M |
| 310 | AVBP | ArriVent BioPharma, Inc. | 1.54B | 3.37% | 542,155 | - |
| 311 | ZBIO | Zenas BioPharma, Inc. | 1.54B | 11.61% | 537,575 | 10.00M |
| 312 | STAA | STAAR Surgical Company | 1.52B | 5.46% | 281,288 | 290.38M |
| 313 | ABSI | Absci Corporation | 1.52B | -3.33% | 8,574,663 | 1.84M |
| 314 | ARDX | Ardelyx, Inc. | 1.51B | -1.45% | 1,180,164 | 427.68M |
| 315 | MAZE | Maze Therapeutics, Inc. | 1.50B | 1.84% | 378,707 | 20.00M |
| 316 | MLTX | MoonLake Immunotherapeutics | 1.48B | 0.30% | 965,372 | - |
| 317 | SVRA | Savara Inc. | 1.48B | -0.17% | 828,747 | - |
| 318 | AAPG | Ascentage Pharma Group International | 1.46B | -0.35% | 5,208 | 82.08M |
| 319 | CDNA | CareDx, Inc. | 1.45B | 3.65% | 714,605 | 412.82M |
| 320 | TDOC | Teladoc Health, Inc. | 1.43B | 1.60% | 2,110,523 | 2.51B |
| 321 | MPLT | MapLight Therapeutics, Inc. | 1.43B | 2.77% | 172,927 | - |
| 322 | ATRC | AtriCure, Inc. | 1.42B | -0.71% | 426,488 | 552.16M |
| 323 | DMRA | Damora Therapeutics, Inc. | 1.40B | 3.23% | 194,968 | - |
| 324 | IART | Integra LifeSciences Holdings Corporation | 1.39B | 0.67% | 376,908 | 1.64B |
| 325 | NVAX | Novavax, Inc. | 1.38B | -5.90% | 2,419,818 | 596.34M |
| 326 | ATEC | Alphatec Holdings, Inc. | 1.37B | 2.07% | 1,003,924 | 787.08M |
| 327 | INNV | InnovAge Holding Corp. | 1.36B | 3.41% | 169,440 | 949.17M |
| 328 | INBX | Inhibrx Biosciences, Inc. | 1.36B | -2.92% | 96,467 | 1.30M |
| 329 | BLFS | BioLife Solutions, Inc. | 1.35B | 8.41% | 1,222,231 | 101.66M |
| 330 | IMTX | Immatics N.V. | 1.35B | -1.40% | 143,502 | 43.00M |
| 331 | PRGO | Perrigo Company plc | 1.35B | -0.10% | 1,156,724 | 4.18B |
| 332 | ARDT | Ardent Health, Inc. | 1.34B | -0.43% | 313,545 | 6.43B |
| 333 | AHCO | AdaptHealth Corp. | 1.32B | -1.00% | 644,759 | 3.29B |
| 334 | PSNL | Personalis, Inc. | 1.32B | 10.87% | 2,846,360 | 64.52M |
| 335 | COAG | Hemab Therapeutics Holdings, Inc. | 1.32B | -1.93% | 50,627 | - |
| 336 | JBIO | Jade Biosciences, Inc. | 1.30B | -0.14% | 496,835 | - |
| 337 | KMTS | Kestra Medical Technologies, Ltd. | 1.30B | 0.68% | 87,371 | 83.72M |
| 338 | PAHC | Phibro Animal Health Corporation | 1.28B | 0.48% | 47,025 | 1.50B |
| 339 | XERS | Xeris Biopharma Holdings, Inc. | 1.27B | -0.20% | 1,257,127 | 314.85M |
| 340 | ENOV | Enovis Corporation | 1.27B | 3.55% | 310,352 | 2.28B |
| 341 | AVLN | Avalyn Pharma Inc. | 1.24B | -1.53% | 134,062 | - |
| 342 | INSP | Inspire Medical Systems, Inc. | 1.24B | -0.53% | 194,674 | 915.25M |
| 343 | PNTG | The Pennant Group, Inc. | 1.24B | 2.89% | 84,812 | 1.02B |
| 344 | ALVO | Alvotech | 1.23B | -0.68% | 415,294 | 562.04M |
| 345 | AMN | AMN Healthcare Services, Inc. | 1.23B | -0.16% | 283,895 | 3.42B |
| 346 | IRMD | IRADIMED CORPORATION | 1.21B | 0.18% | 51,474 | 86.28M |
| 347 | SDGR | Schrödinger, Inc. | 1.20B | 4.44% | 1,147,087 | 254.91M |
| 348 | PRCT | PROCEPT BioRobotics Corporation | 1.19B | 0.48% | 578,836 | 322.02M |
| 349 | EYPT | EyePoint, Inc. | 1.18B | -2.50% | 758,869 | 7.61M |
| 350 | MNKD | MannKind Corporation | 1.17B | -1.43% | 1,408,590 | 360.78M |
| 351 | AVNS | Avanos Medical, Inc. | 1.17B | -0.18% | 194,929 | 715.90M |
| 352 | AHG | Akso Health Group | 1.16B | - | 868 | 14.84M |
| 353 | AZTA | Azenta, Inc. | 1.15B | 4.34% | 309,500 | 596.48M |
| 354 | COLL | Collegium Pharmaceutical, Inc. | 1.13B | -1.71% | 77,765 | 796.33M |
| 355 | CGEM | Cullinan Therapeutics, Inc. | 1.13B | 4.31% | 628,483 | - |
| 356 | OPK | OPKO Health, Inc. | 1.13B | 0.34% | 823,891 | 581.12M |
| 357 | WVE | Wave Life Sciences Ltd. | 1.13B | -1.51% | 1,382,162 | 71.80M |
| 358 | AORT | Artivion, Inc. | 1.12B | 4.86% | 512,306 | 458.69M |
| 359 | OMDA | Omada Health, Inc. | 1.11B | 0.81% | 286,545 | 283.30M |
| 360 | CRVS | Corvus Pharmaceuticals, Inc. | 1.10B | 1.08% | 765,391 | - |
| 361 | XNCR | Xencor, Inc. | 1.09B | 1.59% | 432,566 | 97.36M |
| 362 | MGTX | MeiraGTx Holdings plc | 1.09B | 1.29% | 504,227 | 79.76M |
| 363 | CNMD | CONMED Corporation | 1.06B | -0.17% | 132,914 | 1.37B |
| 364 | TNDM | Tandem Diabetes Care, Inc. | 1.06B | 2.86% | 1,200,092 | 1.03B |
| 365 | BIOA | BioAge Labs, Inc. | 1.03B | 1.31% | 663,265 | 10.32M |
| 366 | NUTX | Nutex Health Inc. | 1.03B | 0.99% | 36,541 | 879.95M |
| 367 | USPH | U.S. Physical Therapy, Inc. | 1.02B | 1.01% | 116,389 | 787.69M |
| 368 | CRON | Cronos Group Inc. | 1.02B | -0.37% | 483,909 | 159.54M |
| 369 | LXRX | Lexicon Pharmaceuticals, Inc. | 1.01B | 2.93% | 2,365,232 | 69.64M |
| 370 | LMRI | Lumexa Imaging Holdings, Inc. | 1.01B | 5.71% | 395,894 | 1.03B |
| 371 | SPTX | Seaport Therapeutics, Inc. | 1.00B | -3.03% | 55,315 | - |
| 372 | SANA | Sana Biotechnology, Inc. | 992.67M | 0.91% | 1,631,091 | - |
| 373 | AVR | Anteris Technologies Global Corp. | 989.97M | -2.21% | 682,069 | 1.85M |
| 374 | ORIC | ORIC Pharmaceuticals, Inc. | 987.56M | 1.17% | 721,305 | - |
| 375 | OLMA | Olema Pharmaceuticals, Inc. | 978.29M | 0.54% | 1,387,704 | - |
| 376 | DRTS | Alpha Tau Medical Ltd. | 974.80M | 7.56% | 680,890 | - |
| 377 | EVO | Evotec SE | 971.12M | 1.49% | 50,311 | 859.03M |
| 378 | DBVT | DBV Technologies S.A. | 955.23M | 2.82% | 540,427 | 5.74M |
| 379 | AVTX | Avalo Therapeutics, Inc. | 949.86M | -0.50% | 943,113 | 59.00K |
| 380 | PCRX | Pacira BioSciences, Inc. | 949.07M | 0.67% | 167,196 | 734.86M |
| 381 | ETON | Eton Pharmaceuticals, Inc. | 947.50M | 1.80% | 177,012 | 86.93M |
| 382 | PHAR | Pharming Group N.V. | 941.11M | -0.15% | 9,865 | 369.49M |
| 383 | INMD | InMode Ltd. | 939.61M | 0.27% | 713,799 | 374.64M |
| 384 | KURA | Kura Oncology, Inc. | 939.23M | -0.38% | 805,142 | 71.64M |
| 385 | AMPH | Amphastar Pharmaceuticals, Inc. | 926.61M | -0.02% | 220,158 | 720.53M |
| 386 | JANX | Janux Therapeutics, Inc. | 923.30M | 3.42% | 3,179,947 | 13.73M |
| 387 | REPL | Replimune Group, Inc. | 923.16M | -0.80% | 1,256,653 | - |
| 388 | GDRX | GoodRx Holdings, Inc. | 922.89M | -1.27% | 437,288 | 787.89M |
| 389 | QDEL | QuidelOrtho Corporation | 904.21M | 8.60% | 641,380 | 2.66B |
| 390 | SLDB | Solid Biosciences Inc. | 899.83M | -1.19% | 838,525 | - |
| 391 | TBPH | Theravance Biopharma, Inc. | 891.35M | 0.12% | 137,983 | 109.78M |
| 392 | GERN | Geron Corporation | 888.51M | - | 6,707,931 | 196.12M |
| 393 | ANRO | Alto Neuroscience, Inc. | 881.91M | 0.88% | 170,224 | - |
| 394 | LBRX | LB Pharmaceuticals Inc | 881.81M | 0.89% | 119,782 | - |
| 395 | ODTX | Odyssey Therapeutics, Inc. | 878.08M | -0.70% | 97,889 | 1.06M |
| 396 | EVMN | Evommune, Inc. | 870.92M | 2.63% | 250,772 | 10.00M |
| 397 | TALK | Talkspace, Inc. | 870.23M | 0.10% | 1,521,992 | 238.37M |
| 398 | DSGN | Design Therapeutics, Inc. | 859.41M | -0.15% | 350,021 | - |
| 399 | ABUS | Arbutus Biopharma Corporation | 857.31M | -2.69% | 1,368,534 | 191.45M |
| 400 | ANNX | Annexon, Inc. | 845.43M | -2.64% | 2,466,089 | - |
| 401 | CERT | Certara, Inc. | 844.72M | - | 1,156,433 | 419.75M |
| 402 | ESPR | Esperion Therapeutics, Inc. | 812.20M | 0.16% | 4,096,770 | 418.24M |
| 403 | VOR | Vor Biopharma Inc. | 807.37M | 2.90% | 469,854 | - |
| 404 | PHAT | Phathom Pharmaceuticals, Inc. | 804.63M | -4.52% | 638,197 | 204.89M |
| 405 | BVS | Bioventus Inc. | 804.44M | 1.37% | 348,146 | 576.30M |
| 406 | SPRY | ARS Pharmaceuticals, Inc. | 794.43M | -24.10% | 5,567,148 | 98.99M |
| 407 | GMRS | GMR Solutions Inc. | 773.99M | 5.45% | 190,574 | 5.83B |
| 408 | ZVRA | Zevra Therapeutics, Inc. | 772.63M | -0.08% | 620,103 | 122.29M |
| 409 | OMER | Omeros Corporation | 763.92M | -0.24% | 499,351 | 9.89M |
| 410 | AURA | Aura Biosciences, Inc. | 761.07M | -1.99% | 102,871 | - |
| 411 | HSTM | HealthStream, Inc. | 749.08M | -1.80% | 54,690 | 311.78M |
| 412 | SIBN | SI-BONE, Inc. | 738.42M | 1.90% | 183,358 | 206.22M |
| 413 | CLYM | Climb Bio, Inc. | 735.80M | 0.78% | 696,068 | - |
| 414 | IVA | Inventiva S.A. | 733.72M | - | 410,851 | 7.94M |
| 415 | CBLL | CeriBell, Inc. | 725.46M | 2.74% | 204,022 | 95.07M |
| 416 | NVCT | Nuvectis Pharma, Inc. | 724.94M | 11.64% | 490,691 | - |
| 417 | OCS | Oculis Holding AG | 719.22M | 3.03% | 293,699 | 1.40M |
| 418 | ALLO | Allogene Therapeutics, Inc. | 714.47M | 0.98% | 6,759,006 | 22.00K |
| 419 | SSII | SS Innovations International, Inc. | 711.47M | 0.99% | 21,254 | 48.47M |
| 420 | CTMX | CytomX Therapeutics, Inc. | 710.80M | -1.66% | 1,366,555 | 35.54M |
| 421 | BBNX | Beta Bionics, Inc. | 703.63M | 7.20% | 489,754 | 110.24M |
| 422 | IMMX | Immix Biopharma, Inc. | 697.66M | -2.39% | 628,280 | - |
| 423 | CADL | Candel Therapeutics, Inc. | 693.87M | 2.16% | 823,184 | - |
| 424 | ACRS | Aclaris Therapeutics, Inc. | 688.54M | 2.92% | 697,552 | 8.37M |
| 425 | CSTL | Castle Biosciences, Inc. | 676.66M | 0.86% | 155,497 | 339.92M |
| 426 | RLMD | Relmada Therapeutics, Inc. | 675.49M | -1.08% | 1,436,451 | - |
| 427 | RIGL | Rigel Pharmaceuticals, Inc. | 675.14M | -0.16% | 130,819 | 299.77M |
| 428 | DRUG | Bright Minds Biosciences Inc. | 660.55M | -2.81% | 83,311 | - |
| 429 | NNNN | Anbio Biotechnology | 654.42M | -2.23% | 179,602 | 8.65M |
| 430 | TENX | Tenax Therapeutics, Inc. | 651.93M | -1.31% | 466,349 | - |
| 431 | AGMB | AgomAb Therapeutics NV | 648.84M | 3.90% | 44,367 | - |
| 432 | SGP | SpyGlass Pharma, Inc. | 648.27M | -0.82% | 37,837 | - |
| 433 | DNA | Ginkgo Bioworks Holdings, Inc. | 637.57M | 0.31% | 858,849 | 151.40M |
| 434 | SLBT | SL Science Holding Limited | 631.95M | 4.27% | 85,310 | - |
| 435 | TCMD | Tactile Systems Technology, Inc. | 628.19M | 1.31% | 61,713 | 343.52M |
| 436 | IRWD | Ironwood Pharmaceuticals, Inc. | 628.00M | -2.43% | 1,000,596 | 361.51M |
| 437 | CRMD | CorMedix Inc. | 618.20M | -6.08% | 1,916,862 | 400.05M |
| 438 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 616.02M | 3.36% | 208,437 | - |
| 439 | FTH | Faeth Therapeutics, Inc. | 608.89M | -3.75% | 51,875 | - |
| 440 | FDMT | 4D Molecular Therapeutics, Inc. | 607.45M | - | 527,356 | 88.24M |
| 441 | ACHV | Achieve Life Sciences, Inc. | 600.04M | 10.28% | 2,825,769 | - |
| 442 | TRAX | First Tracks Biotherapeutics, Inc. | 591.77M | 1.62% | 350,483 | - |
| 443 | BWAY | BrainsWay Ltd. | 589.17M | 0.97% | 40,039 | 56.22M |
| 444 | MNPR | Monopar Therapeutics Inc. | 587.05M | -1.52% | 140,738 | - |
| 445 | TECX | Tectonic Therapeutic, Inc. | 585.70M | 1.04% | 40,711 | - |
| 446 | CBIO | Crescent Biopharma, Inc. | 579.85M | 0.52% | 67,804 | 11.88M |
| 447 | PRME | Prime Medicine, Inc. | 576.17M | 2.24% | 1,771,944 | 4.03M |
| 448 | CTKB | Cytek Biosciences, Inc. | 575.98M | 4.21% | 804,596 | 204.17M |
| 449 | CERS | Cerus Corporation | 573.06M | 8.33% | 2,635,750 | 216.56M |
| 450 | PHR | Phreesia, Inc. | 565.89M | -4.54% | 668,187 | 495.59M |
| 451 | GYRE | Gyre Therapeutics, Inc. | 565.59M | -4.48% | 40,529 | 117.05M |
| 452 | MDXG | MiMedx Group, Inc. | 564.50M | -1.04% | 452,942 | 389.42M |
| 453 | ALT | Altimmune, Inc. | 563.98M | -1.69% | 1,713,292 | 36.00K |
| 454 | EVH | Evolent Health, Inc. | 562.41M | -0.60% | 1,041,268 | 1.89B |
| 455 | ANGO | AngioDynamics, Inc. | 562.29M | 4.17% | 142,950 | 313.73M |
| 456 | NPCE | NeuroPace, Inc. | 556.07M | 0.55% | 70,196 | 99.53M |
| 457 | EIKN | Eikon Therapeutics, Inc. | 549.51M | 5.40% | 199,862 | - |
| 458 | CTEV | Claritev Corporation | 548.09M | 5.44% | 50,311 | 978.76M |
| 459 | AQST | Aquestive Therapeutics, Inc. | 547.59M | -12.53% | 3,689,000 | 50.27M |
| 460 | FLGT | Fulgent Genetics, Inc. | 546.14M | 0.52% | 117,484 | 320.35M |
| 461 | RGNX | REGENXBIO Inc. | 540.24M | 4.81% | 866,350 | 87.82M |
| 462 | CLPT | ClearPoint Neuro, Inc. | 536.81M | -0.44% | 408,825 | 40.61M |
| 463 | TLRY | Tilray Brands, Inc. | 530.81M | -3.05% | 2,312,217 | 858.28M |
| 464 | XOMA | XOMA Royalty Corporation | 527.73M | -0.17% | 53,067 | 48.56M |
| 465 | ARVN | Arvinas, Inc. | 520.04M | 0.12% | 232,297 | 89.40M |
| 466 | RZLT | Rezolute, Inc. | 515.02M | -1.99% | 367,559 | - |
| 467 | TOI | The Oncology Institute, Inc. | 510.91M | -2.67% | 567,921 | 545.76M |
| 468 | MYGN | Myriad Genetics, Inc. | 508.60M | 3.16% | 1,247,428 | 829.00M |
| 469 | STRO | Sutro Biopharma, Inc. | 507.72M | 2.03% | 141,804 | 99.61M |
| 470 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 471 | CTNM | Contineum Therapeutics, Inc. | 503.97M | 5.15% | 208,770 | - |
| 472 | PROK | ProKidney Corp. | 501.42M | -6.21% | 639,582 | 889.00K |
| 473 | KIDS | OrthoPediatrics Corp. | 499.83M | 1.67% | 68,951 | 243.30M |
| 474 | KYTX | Kyverna Therapeutics, Inc. | 499.74M | -4.64% | 1,053,327 | - |
| 475 | PACB | Pacific Biosciences of California, Inc. | 493.86M | 10.42% | 8,747,705 | 160.03M |
| 476 | ASMB | Assembly Biosciences, Inc. | 492.36M | -3.02% | 128,562 | 71.10M |
| 477 | PRTA | Prothena Corporation plc | 488.98M | -0.64% | 210,555 | 57.94M |
| 478 | NGNE | Neurogene Inc. | 482.91M | 1.63% | 87,287 | 925.00K |
| 479 | CCCC | C4 Therapeutics, Inc. | 474.89M | 1.06% | 1,416,312 | 34.86M |
| 480 | VALN | Valneva SE | 474.76M | -0.38% | 21,865 | 180.25M |
| 481 | CABA | Cabaletta Bio, Inc. | 472.86M | -4.29% | 2,315,163 | - |
| 482 | SRTA | Strata Critical Medical, Inc. | 469.41M | -1.54% | 530,043 | 228.58M |
| 483 | EOLS | Evolus, Inc. | 467.57M | 1.87% | 257,446 | 301.79M |
| 484 | OCGN | Ocugen, Inc. | 463.77M | -1.44% | 3,862,228 | 4.47M |
| 485 | BNTC | Benitec Biopharma Inc. | 463.61M | -0.99% | 129,348 | - |
| 486 | STTK | Shattuck Labs, Inc. | 462.38M | 0.33% | 767,728 | 1.00M |
| 487 | FBRX | Forte Biosciences, Inc. | 460.12M | 1.56% | 82,988 | - |
| 488 | SOPH | SOPHiA GENETICS SA | 458.50M | 0.91% | 176,706 | 81.18M |
| 489 | NRC | NRC Health | 458.06M | -1.81% | 22,069 | 138.64M |
| 490 | VMD | Viemed Healthcare, Inc. | 449.69M | 2.27% | 264,157 | 286.57M |
| 491 | OVID | Ovid Therapeutics Inc. | 448.87M | -3.80% | 1,199,928 | 7.12M |
| 492 | SLN | Silence Therapeutics plc | 448.72M | 3.71% | 734,871 | 839.00K |
| 493 | VREX | Varex Imaging Corporation | 445.07M | 1.83% | 118,633 | 857.50M |
| 494 | EDIT | Editas Medicine, Inc. | 436.60M | 1.61% | 2,169,163 | 38.69M |
| 495 | VTVT | vTv Therapeutics Inc. | 434.33M | -2.07% | 46,158 | 36.84M |
| 496 | AUTL | Autolus Therapeutics plc | 433.81M | 2.52% | 384,864 | 92.62M |
| 497 | ARTV | Artiva Biotherapeutics, Inc. | 433.65M | -4.24% | 219,075 | 251.00K |
| 498 | SI | Shoulder Innovations, Inc. | 431.98M | 5.36% | 61,558 | 53.89M |
| 499 | CYH | Community Health Systems, Inc. | 431.42M | 0.79% | 375,297 | 12.29B |
| 500 | ZURA | Zura Bio Limited | 430.34M | 6.34% | 718,734 | - |